Delivering Safer, More Effective, & Globally Accessible Gene Therapies to Patients
Gene therapy is a rich ground for development and innovation. With recent market approvals and advances in clinical programs demonstrating further proof of concept, the next generation of gene therapies are now proving their curative potential.
It’s therefore never been so important to understand how gene therapy developers are navigating unique development, manufacturing, and commercial challenges to drive forward the next wave of safe, effective gene therapies.
To do this, our gene therapy product offerings are curated through close collaboration with industry leaders to give you high-quality and granular insight across all disease indications. By delving into early R&D, clinical safety and efficacy, manufacturing, regulatory, and market access challenges, as well as showcasing the next generation of novel vector development in AAV and beyond, we can together realize the full promise of gene therapies together.